Experts agree that most patients younger than 65 should be treated with surgery instead of TAVR. According to a new real-world analysis, however, more and more of these patients are undergoing TAVR.

Concerns about radiation are believed to be a major reason so few women pursue a career in interventional cardiology. Are they right to be worried? SCAI hopes its new analysis can shed some light on this topic. 

The new device from Arizona-based Corvention was built to withstand the extreme pressures associated with treating severely calcified valves. 

The company's Seismiq platform has already gained FDA approval for treating PAD. This new analysis highlights its potential to treat calcified coronary lesions during PCI procedures.

Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.

The physician was accused of pressuring Medicare patients into undergoing treatment they did not need. One patient allegedly received 42 different stents over an eight-year period.

Researchers reviewed dozens of studies to evaluate the long-term value of using CCTA guidance to perform PCI on patients with complete blockages.

When heart patients require aortic valve replacement, would they be a better fit for TAVR or SAVR? Such decisions are not made lightly, clinicians emphasized in a new joint statement.